Whats Next - Drug Wise after IbsrelaI might not have said it explicitly, but I am a fan of Ibsarela and GUD's partnership. I also have the luxury or not caring what they paid for it and really hope to sidestep that whole part of the conversation. The primary use of this drug looks profitable to GUD from where I sit and the possibility of a secondary use is appealing. SO - what are every bodies thoughts on the next drug or drugs to be approved at GUD and does anybody have any guesses on when that might be. Thanks in advance for valuable, forward looking commentary.